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The outcome of Helicobacter pylori infection has been related to specific virulence-associated bacterial
genotypes. The vacuolating cytotoxin (vacA), cagA gene, oipA and babA2 gene are important virulence
factor involving gastric diseases. The objective of this study was to assess the relationship between
virulence factors of H. pylori and histopathological findings.
Material and methods: Gastroduodenoscopy was performed in 436 dyspeptic patients. Antrum biopsy
was obtained for detection of H. pylori, virulence factors and for histopathological assessment. The po-
lymerase chain reaction was used to detect virulence factors of H. pylori using specific primers.
Results: vacA genotypes in patients infected with H. pyloriwere associated with cagA, iceA1 and iceA2. In
the patients with H. pylori infection there was a significant relationship between cagA positivity and
neutrophil activity (P ¼ 0.004) and chronic inﬂammation (P ¼ 0.013) and with H. pylori density
(P ¼ 0.034). Neutrophil infiltration was found to be more severe in the s1 group than in the s2 group
(P ¼ 0.042). Also was a significant relationship between oipA positivity and neutrophil activity
(P ¼ 0.004) and with H. pylori density (P ¼ 0.018). No significant relationships were observed between
other vacA genotypes and histopathological parameters.
Conclusion: H. pylori strains showing cagA, vacA s1 and oipA positivity are associated with more severe
gastritis in some histological features but virulence factors of H. pylori do not appear to determine the
overall pattern of gastritis.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Helicobacter pylori (H. pylori) is an important human pathogen
that colonize the stomach. This bacterium induces gastritis, peptic
ulcer and is associated with gastric carcinoma [1,2]. The clinical
outcome of H. pylori infection has been associated with bacterial
virulence factors, host gastric mucosal factors, and the environment
[3]. But relationship between H. pylori genotype and its association
with clinical outcome is not fully understood. Several possible951@yahoo.com (H. Shirzad).disease-speciﬁc virulence factors have been suggested to be asso-
ciated with H. pylori infection [4e7]. The main bacterial virulence
factors include adhesins (BabA, SabA), the vacuolating cytotoxin
VacA, and the products of the cag pathogenicity island (cag PAI).
CagA was the most examined putative virulence factor and it is
encoded by the cagA gene. A number of studies have conﬁrmed that
infection with cagA-positive strains is associated with more severe
gastritis and higher prevalence of peptic ulcer and gastric cancer in
western countries [8,9]. Conversely, relationship between cagA-
positive status and its association with clinical outcome are not
fully understood in Asian countries, where the majority of the
H. pylori strains are cagA-positive [10e12]. The vacuolating cyto-
toxin A gene, which is another important virulence factor of
L. Salimzadeh et al. / Microbial Pathogenesis 80 (2015) 67e7268H. pylori, the vacA is present in all H. pylori strains and induces
vacuolation of epithelial cells [8]. The vacA gene includes two
variable parts. The H. pylori strains have one of two types of vacA
signal sequence (s1 and s2) and two types of mid region (m1 and
m2). Cytotoxin production and virulence are higher in the s1/m1
subtypes than in the s1/m2 subtype, and lower still in the s2/m2
subtype [13]. Similar cagA status, there are geographic differences
between vacA status and the H. pylori-related diseases. In western
countries infection with vacA s1 strain is more common in patients
with peptic ulcer than in those with chronic gastritis. However in
Asian countries, the association between vacA diversity and clinical
outcome is not established [14]. BabA is an adhesion molecule that
mediates the attachment of H. pylori to Lewis b blood group anti-
gens on human gastric epithelial cells [15]. Three bab alleles have
been identiﬁed: babA1, babA2, and babB and only the babA2 gene
product is necessary for Lewis b binding activity [15]. Studies in
western countries have shown that about 70% of H. pylori strains in
Western countries were typed as babA2, whichwas associated with
increased virulence [16]. Moreover, the triple-positive phenotype
(babA2, cagA, and vacA s1) was detected at a higher frequency in
isolates from patients with ulcers and adenocarcinomas, which
might serve as useful markers of high-risk patients in western
countries [16]. The iceA gene is induced by contact with epithelium
and has two main allelic variants, iceA1 and iceA2. The presence of
iceA1 allele is associated with peptic ulcer disease in western
countries [17]. OipA is a proinﬂammatory response-inducing pro-
tein associated with high H. pylori density and more severe
neutrophil inﬁltration. OipA mediates adherence of H. pylori to
gastric epithelial cells and contributes to the pathogenesis of
gastroduodenal diseases [18]. Therefore, the aim of this study was
to analyze the frequency of virulence factors and to correlate the
presence of babA2 with cagA, oipA and vacA, iceA genotypes ofFig. 1. Histological examination. (A) Mild chronic superﬁcial gastritis with chronic inﬂam
borderline biopsy sample and illustrates the least number of cells acceptable for a diagnos
gastritis. (C) H. pylori organisms present in the mucous layer on the gastric mucosal surfacH. pylori strains in Iran patients and to study its associationwith the
histologic severity of gastritis.
2. Materials and methods
2.1. Study population
The subjects included in this study were 436 patients with non-
ulcer dyspepsia (NUD) (195 patients with H. pylori infection and
241 H. pylori uninfection), having recurrent abdominal pain from
endoscopy unit of the Hajar Hospital in Shahrekord, Iran. From each
patient, written consent was obtained and 3 biopsies were
collected from gastric antrum. Two specimens were used for rapid
urease test and DNA extraction, and one specimen was used for
histopathology study. H. pylori-infection was determined by the
rapid urease test, PCR (16srRNA and glmM) and histological ex-
amination of biopsies taken from the corpus. Patients were classi-
ﬁed as H. pylori-infected only if the four tests were positive,
respectively. This study was performed by the Ethics Committee
approval No: 1025 of Shahrekord University of Medical Sciences,
Shahrekord, Iran.
2.2. Histological examination
Sections of biopsy specimens were embedded in 10% buffered
formalin and stained with hematoxylin and eosin to examine
gastritis and with giemsa to detect H. pylori (Fig. 1). The histological
severity of gastritis was blindly graded from normal to severe based
on the degree of mononuclear cell (MNC) and polymorphonuclear
leukocyte (PMN) inﬁltration, and atrophy according to the Updated
Sydney system [19] on a four-point scale: 0, no; 1, mild; 2, mod-
erate; and 3, severe changes.matory cells present in the superﬁcial lamina propria in excess of normal. This is a
is of gastritis. (B) Gastric pits inﬁltrated by neutrophils in a case of Helicobacter pylori
e (400).
Table 1
Demographic data of study subjects.
Variable H. pylori infected (%) H. pylori uninfected (%) P Value
Total 195 (44.4%) 241 (55.6%) 0.56
Gender
Male 80 (41.9%) 106 (58.1%)
Female 115 (46.2%) 136 (53.8%)
Mean ± SD (year) 46.74 ± 16.79 48.56 ± 19.82 0.298
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DNA for polymerase chain reaction (PCR) was extracted using
the Biospin Tissue Genomic DNA Extraction Kit (BioFlux, Japan).
Detection of virulence factors was performed by PCR and reported
by bagheri et al. [4,20]. For vacA, cagA, iceA and babA2 evaluation,
the PCR program comprised 35 cycles of denaturation (at 94 C for
30 s), annealing (at 56 C for 30 s, extension at 72 C for 30 s), and
one ﬁnal extension (at 72 C for 5 min). For oipA, ampliﬁcation was
performed with 35 cycles of denaturation (at 94 C for 30 s,
annealing at 60 C for 30 s, extension at 72 C for 30 s), and one ﬁnal
extension (at 72 C for 5 min).Fig. 2. H. pylori diagnostic by PCR and vacA, cagA, iceA1/2, oipA and babA2 genotypes. (A) an
and (B) M, 100-bp ladder marker. (2e6) 294 bp H. pylori glmM. (C) H. pylori vacA (middle seq
vacA (signal sequence) genotype: 259 bp (s1 allele); 286 bp (s2 allele). (D) H. pylori cagA gen
genotype: M, 100-bp ladder marker. (2e6) 271 bp, babA2-positive strains. (F) H. pylori iceA1
iceA2 genotype: M, 100-bp ladder marker. (1 and 3e6) 229 or 334 bp, iceA2-positive strain
strains.2.4. Statistical analysis
All data are expressed as mean ± SEM. Age was analyzed by
unpaired Student's T-Test. The Chi-squared (c2) and Fisher's exact
test were used for analyzing categorical variables data and to
compare differences in the prevalence of H. pylori genotypes. Sta-
tistical analysis of the data was carried out by SPSS, version 16,
statistical software program and ANOVA was used for continuing
data. A P values <0.05were considered to be statistically signiﬁcant.
3. Results
The characteristics of the population studied are listed in Table 1.
There was no significant difference between H. pylori infected and
H. pylori uninfected subjects with respect to the age and gender
distribution. Also Fig. 2 shows the results of electrophoresis of PCR
products.
3.1. Genotypes
Results of PCR product indicating the presence of the cagA gene
was obtained with 139 patients with H. pylori infection (71.2%) andd (B) H. pylori diagnostic: (A) M, 100-bp ladder marker. (2e6) 109 bp H. pylori 16srRNA
uence) genotype: M, 100-bp ladder marker. 567 bp (m1 allele); 642 bp (m2 allele) and
otype: M, 100-bp ladder marker. (2e6) 232 bp, cagA-positive strains. (E) H. pylori babA2
genotype: M, 100-bp ladder marker. (2e5) 247 bp, iceA1-positive strains. (G) H. pylori
s. (H) H. pylori oipA genotype: M, 100-bp ladder marker. (2e6) 430 bp, oipA-positive
Table 2
Prevalence of H. pylori genotypes detected in patients.
Genotype Prevalence
cagA
cagA positive 139 (71.2%)
cagA negative 56 (28.8%)
vacA
s1 positive 151 (77.4%)
s2 positive 30 (15.3%)
s1s2 positive 9 (4.6%)
s1s2 negative 5 (2.5%)
m1 positive 48 (24.6%)
m2 positive 125 (64.1%)
m1m2 positive 18 (9.2%)





Other genotype 32 (16.4%)
iceA
iceA1 positive 100 (51.2%)
iceA2 positive 61 (31.2%)
iceA1/iceA2 positive 16 (8.2%)
iceA1/iceA2 negative 18 (9.2%)
oipA
oipA positive 187 (95.9%)
oipA negative 8 (4.1%)
babA2
babA2 positive 168 (86.1%)
babA2 negative 27 (13.9%)
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(9.2%) contained both m1 and m2 alleles. In the patients containing
one single vacA m allele, the m1 allele was found in 48 patients
(24.6%) and m2 in 125 one (64.1%). In the s-region, 9 patients (4.6%)
contained both m1 and m2 alleles. In the patients containing one
single vacA s allele, the s1 allele was found in 151 patients (77.4%)
and s2 in 30 one (15.3%). The vacA genotype s1/m1, s1m2 and s2m1
were detected in 55 (28.2%), 79 (40.5%) and 29 (14.8%) patients. The
s2m2 genotype was not found in our study. The oipA and babA2
genes were detected in 187 (95.9%) and 168 (86.1%) patients.
Overall, iceA1 was detected in 100 patients (51.2%) of all 281 pa-
tients and iceA2 was found in 61 patients (31.2%). 16 patients (8.2%)
were positive for both iceA1 and iceA2 and 18 patients (9.2%) were
negative for both iceA1 and iceA2 (Table 2).
3.2. Correlation of vacA alleles and presence virulence factors
The cagA gene was detected in 139 (71.2%) patients with
H. pylori infection. The association between vacA alelles and pres-
ence virulence factors is described in Table 3. Of the 139 patients
infectedwithH. pylori that were positive for cagA,115 patients wereTable 3
Correlation of vacA alleles with the cagA, babA2, and iceA genotype of the samples stud
vacA genotype cagA babA2
Positive Negative Positive Neg
s1m1 43 9 48 5
s1m2 61 19 63 17
s2m2 13 16 26 3
P value 0.001 0.128
s1 115 33 125 23
s2 13 17 27 3
P value 0.000 0.576
m1 43 10 48 5
m2 78 40 98 20
P value 0.046 0.198associated with the toxin-producing vacA s1 and only 33 patients
with cagA-positive were vacA s2. Of the 139 patients with H. pylori
infection that were positive for cagA, 43 patients were associated
with vacA s1m1, 61 patients were associated with vacA s1m2 and
only 13 patients with cagA-positive were vacA s2m2. Also vacA
genotypes in patients infected with H. pylori were associated with
iceA1 and iceA2 (Table 3).
3.3. H. pylori density
The density of H. pylori was scored in gastric biopsy specimens.
The density scores of H. pylori in patients with cagA and oipA
positive were higher than in the cagA and oipA negative (Table 4).
There was no significant relationship between other virulence
factors and H. pylori density.
3.4. Neutrophil activity
CagA, oipA and vacA s1 positive genotypes were strongly asso-
ciated with higher neutrophil activity in gastric biopsy specimens
(Table 4). No relationships were found between neutrophil activity
and other virulence factors in gastric biopsy specimens.
3.5. Chronic inﬂammation
There was an association between cagA positivity and high
inﬂammation scores in gastric biopsy specimens (p ¼ 0.013). There
was no relationship between other virulence factors and chronic
inﬂammation in gastric biopsy specimens (Table 4).
4. Discussion
H. pylori infection results in chronic gastritis and, eventually,
diseases, such as peptic ulcer, gastric cancer, and MALT lymphoma
[1,3]. Genotypic alterations of H. pylori are thought to be respon-
sible for the various clinical manifestations and for infection
without symptoms or with symptoms of gastric carcinoma and
MALT lymphoma. In our study, the presence of virulence factors,
which is thought to be associated with severe diseases, was
investigated in patients with functional dyspepsia and compared
with histological findings. Although an association between
H. pylori infection and chronic gastritis is clear, development of
severe gastric diseases is rare. These variations in the clinical con-
sequences are because of factors such as duration of the infection,
inﬂammatory response of the patient, virulence of H. pylori strains.
Infection with less virulent strains is associated with mild symp-
toms whereas infection with more virulent strains is thought to be
associated with more severe gastric inﬂammation and, eventually,
peptic ulcer, gastric adenoma, and MALT lymphoma. Theied.
iceA1 iceA2
ative Positive Negative Positive Negative
37 16 16 37
48 32 34 46
9 20 17 12
0.003 0.042
96 52 52 96
10 20 17 13
0.001 0.027
38 15 15 38
61 57 57 61
0.014 0.014
Table 4
Relationship between histological parameters determined in gastric biopsy speci-
mens and H. pylori cagA status.
Genotype Neutrophil activitya Chronic inﬂammationa H. pylori density
cagA (þ) 0.99 (0e3) 1.88 (0e3) 1.80 (0e3)
cagA (þ) 0.59 (0e3) 1.61 (0e3) 1.56 (0e3)
Pb 0.004 0.013 0.034
vacA m1 1.00 (0e3) 1.75 (0e3) 1.51 (0e3)
vacA m2 0.79 (0e3) 1.50 (0e3) 1.49 (0e3)
0.135 0.057 0.869
vacA s1 0.94 (0e3) 1.61 (0e3) 1.47 (0e3)
vacA s2 0.59 (0e3) 1.34 (0e3) 1.47 (0e3)
Pb 0.042 0.1 0.998
s1m1 1.00 (0e3) 1.72 (0e3) 1.55 (0e3)
s1m2 0.88 (0e3) 1.56 (0e3) 1.54 (0e3)
s2m2 0.59 (0e3) 1.28 (0e3) 1.53 (0e3)
Pb 0.06 0.576 0.996
iceA1 (þ) 0.86 (0e3) 1.64 (0e3) 1.54 (0e3)
iceA1 () 0.90 (0e3) 1.44 (0e3) 1.42 (0e3)
Pb 0.787 0.079 0.236
iceA2 (þ) 0.85 (0e3) 1.53 (0e3) 1.55 (0e3)
iceA2 () 0.90 (0e3) 1.57 (0e3) 1.45 (0e3)
Pb 0.658 0.731 0.309
babA2 (þ) 0.89 (0e3) 1.57 (0e3) 1.51 (0e3)
babA2 () 0.81 (0e3) 1.44 (0e3) 1.41 (0e3)
Pb 0.673 0.431 0.475
oipA (þ) 0.91 (0e3) 1.55 (0e3) 1.51 (0e3)
oipA () 0.25 (0e3) 1.62 (0e3) 1.12 (0e3)
Pb 0.032 0.797 0.018
a The histopathological parameters were scored as: 0, none; 1, mild; 2, moderate;
3, severe.
b Mean scores were compared with the t test.
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inﬂammatory response varies within nationalities. In Western
countries it has been demonstrated that more severe gastric
inﬂammation develops after infectionwith cagA-positive strains; in
Asian countries there is no such difference. Studies from Turkey on
cagA positivity and the histopathological findings of gastritis led to
conﬂicting results. Demirturk et al. suggested that cagA positivity is
associated with more severe glandular atrophy, inﬂammation, and
activity, whereas Saruc et al. demonstrated a relationship between
cagA positivity with inﬂammation, H. pylori density, and intestinal
metaplasia but not with glandular atrophy [21,22]. In our study, we
found 71.2% infected patients with cagA-positive which are similar
to some reports from Iran [23] and different from reports of South
and East Asianwhere the presence of cagA strain and its association
with clinical outcomes is more than 90% [24,25]. It has been shown
that the prevalence of cagA-positive strains in USA and Europe is
60e70% [26]. Our results also demonstrate that cagA-positive pa-
tients showed more severe neutrophil infiltration, chronic inﬂam-
mation and H. pylori density in patients infected with H. pylori. The
variability of the vacA s and m regions is thought to have effects
over the secretion of vacuolating toxin. s1/m1 strains produce huge
amounts of toxins and are highly detrimental. s2 strains do not
produce such toxins. In many studies, the variability of the s ge-
notypes is associated with disease formation but not proven. In our
study, we ﬁnd that there is statistically significant relationship
between vacA s1 genotype and neutrophil infiltration. Warburton
et al. reported no relationship between vac s1 and s2 regions and
histological findings [27]. This finding is controversial, because it is
known that strains with s1 genotype produce much greater
amounts of toxins. Subtypes of vacA s1 region may be closely
related to histological parameters. Nevertheless, Atherton et al.
suggested that s1a genotype is associated with peptic ulcer and
more severe gastritis [28]. Our results indicate that oipA-positive
patients were strongly associated with higher neutrophil activity
and H. pylori density in gastric biopsy specimens. oipA expression
was reported to be linked to severe inﬂammation and the inductionof IL-8 secretion and the presence of a functional gene is signi-
ficantly associated with the presence of duodenal ulcers, gastric
cancer, and increased neutrophil infiltration [29,30]. Recent work
using Mongolian gerbils infected with wild-type H. pylori and an
isogenic oipA mutant strain demonstrated a role for oipA in in-
duction of the mucosal cytokines IL-1, IL-17, and tumor necrosis
factor alpha (TNF-a) and in gastric mucosal inﬂammation [31]. In
the present study, iceA1 allele was predominant and was not
associated with the severity of the gastritis. Besides the virulence
factors of H. pylori, variations of acid production, the genetics of the
infected subject, tobacco and alcohol intake may affect both clinical
outcomes and the histopathological findings. More studies are
needed to evaluate other factors besides the H. pylori genotypes,
because H. pylori is thought to be a cause of serious diseases.
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